Media centerClara Prieto2025-06-09T11:49:48+02:00

MEDIA CENTER

Keep up to date with our latest news and resources

PRESS RELEASES

Catch up with the latest updates from our company

Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion

Miguel Martínez-Cava2026-10-01T07:00:04+02:00October 1, 2026|Press releases|

mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide

Miguel Martínez-Cava2026-09-18T07:16:55+02:00September 18, 2026|Press releases|

mAbxience and Amneal Announce FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

Miguel Martínez-Cava2025-12-22T22:02:19+01:00December 22, 2025|Press releases|

BLOG

Dive into the insights from mAbxience, written by our team

What does a company have in common with a cell?

Clara Prieto2025-11-12T12:02:38+01:00November 12, 2025|News|

Can AI optimizations impact every stage of a biologic production process?

Clara Prieto2025-09-03T15:57:35+02:00September 3, 2025|News|

The science behind trust: how biosimilars are developed, proven and delivered to patients

Clara Prieto2025-07-28T13:03:51+02:00July 28, 2025|News|

MULTIMEDIA

Browse our media resources and materials

Similarity Exercise | VIDEO

mAbxience Biosimilar Development | VIDEO

mAbxience León site | VIDEO

mAbxience Argentina | VIDEO

mAbxience | VIDEO

Want to learn all about our CDMO platform? Download the brochure